OpenAI unveils Aardvark, an autonomous AI agent for scalable vulnerability detection and patching Aardvark mimics human researchers: reads code, runs tests, and proposes targeted security fixes In ...
SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
In a digital era where software vulnerabilities can topple companies and compromise entire infrastructures overnight, OpenAI’s latest experiment takes aim at one of technology’s oldest weaknesses: ...
Currently in private beta, the GPT-5-powered security agent scans, reasons, and patches software like a real researcher, aiming to embed AI-driven defense into the development workflow. OpenAI has ...
OpenAI (OPENAI) has released a private beta version of Aardvark, a security research agent that autonomously monitors code to identify and help fix vulnerabilities in software. "Aardvark represents a ...
OpenAI has launched Aardvark, a cybersecurity researcher agent. Aardvark is powered by GPT-5 and is in private beta. It can discover and help fix security vulnerabilities. Aardvark, OpenAI's new ...
An aardvark works in an office typing at a desktop PC while happy human workers mill about in the background. Credit: VentureBeat made with ChatGPT Positioned as a scalable defense tool for modern ...
Aardvark Therapeutics, Inc. announced key leadership appointments to enhance its team as it progresses with its Phase 3 HERO study of ARD-101 for treating hyperphagia associated with Prader-Willi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback